Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (19 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Product and service
0
0
0
0
0
1
Collaborations
0
1
1
0
0
0
Grants
1
0
0
0
0
0
Total revenues
1
1
1
0
1
1
Cost of product revenue
0
0
0
0
0
0
Selling, general, and administrative expenses
1
2
7
13
18
22
Research and development expenses
1
1
3
8
13
18
Loss from operations
-1
-2
-9
-21
-30
-39
Fair value of warrant liabilities in excess of proceeds received.
0
0
-19
0
0
0
Change in fair value of warrant liabilities
0
0
-10
-5
0
0
Financing transaction costs in excess of proceeds received
0
0
-2
0
0
0
Loss on inducement to exercise.
0
0
-2
0
0
0
Loss on disposal of fixed assets
0
0
0
0
0
0
Interest expense
0
-2
-1
0
0
0
Interest income
0
0
0
0
0
0
Other income (expense)
0
0
0
0
0
0
Total other income (expense)
0
-2
-34
-5
0
0
Income tax expense
0
0
0
0
0
0
Net loss
-1
-4
-44
-26
-30
-39
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Jun 10, 2014 n/a
calculated values,
restated on Jun 9, 2015 n/a
calculated values,
restated on Jun 9, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (28 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
0
15
16
48
50
62
Accounts receivable
0
0
0
0
0
0
Inventory, Net
0
0
0
0
0
0
Deferred financing costs
0
0
0
0
0
0
Prepaid expenses and other current assets
0
1
0
1
1
1
Total current assets
1
16
16
49
51
64
Fixed Assets, net
0
1
1
1
2
4
Restricted cash
0
0
0
0
0
0
Other assets, net
0
0
0
0
0
0
Total assets
1
17
17
50
53
68
Liabilities and owners' equity
Accounts payable
1 658000
0 425000
1 641000
0 326000
1 1387000
1 787000
Accrued expenses
0 438000
1 981000
1 780000
1 822000
2 2257000
2 2450000
Deferred rent
0 0
0 0
0 0
0 345000
1 759000
0 139000
Deferred revenue
0 153000
0 0
0 53000
0 13000
0 227000
1 1110000
Capital lease obligation
0 0
0 10000
0 10000
0 10000
0 5000
0 0
Accrued interest payable
0 24000
0 0
0 0
0 0
0 0
0 0
Convertible Notes Payable
1 704000
0 0
0 0
0 0
0 0
0 0
Warrant liabilities
1 1267000
21 20619000
7 6898000
0 377000
0 126000
0 4000
Total current liabilities
2 1977000
22 22035000
8 8382000
2 1893000
5 4761000
4 4490000
Deferred revenue, net of current portion
0 0
0 0
0 9000
0 4000
0 32000
0 0
Deferred rent, net of current portion
0 0
0 17000
0 15000
0 5000
0 0
1 905000
Total liabilities
3 3244000
22 22052000
8 8406000
2 1902000
5 4793000
5 5395000
Commitments and contingencies (Note 6)
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $0.001 par value; 150,000,000 shares authorized, 92,391,989 and 81,536,724 shares issued and outstanding at March 31, 2016 and March 31, 2015, respectively
0 22000
0 59000
0 65000
0 78000
0 82000
0 92000
Additional paid-in capital
5 4835000
45 44883000
75 75269000
140 140419000
171 170909000
223 222959000
Accumulated deficit
-7 -6692000
-50 -50245000
-66 -66365000
-92 -92213000
-122 -122295000
-161 -160870000
Total stockholders’ equity
-2 -1835000
-5 -5303000
9 8969000
48 48284000
49 48696000
62 62181000
Total liabilities and stockholders’ equity
1 1409000
17 16749000
17 17375000
50 50186000
53 53489000
68 67576000
Remarks restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Jun 10, 2014 n/a restated on Jun 9, 2015 n/a restated on Jun 9, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (36 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net loss
-1
-4
-44
-26
-30
-39
Amortization of deferred financing costs
0
0
0
0
0
0
Amortization of warrants issued for services
0
0
1
0
1
0
Depreciation and amortization
0
0
0
0
0
1
Loss on disposal of fixed assets
0
0
0
0
0
0
Amortization of debt discount
0
1
1
0
0
0
Interest accrued on convertible notes payable.
0
0
0
0
0
0
Fair value of warrant liabilities in excess of proceeds received.
0
0
19
0
0
0
Change in fair value of warrant liabilities
0
0
10
5
0
0
Loss on inducement to exercise.
0
0
2
0
0
0
Payment for expense on warrant modification.
0
0
0
0
0
0
Stock-based compensation
0
0
1
5
7
9
Warrants issued in connection with exchange agreement
0
1
0
0
0
0
Increase decrease in grants receivable.
0
0
0
0
0
0
Accounts receivable
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
Prepaid expenses and other assets
0
0
0
0
0
0
Accounts payable
0
0
0
0
1
-1
Accrued expenses
0
0
0
0
1
0
Increase decrease in deferred rent.
0
0
0
0
0
0
Deferred revenue
0
0
0
0
0
1
Net cash used in operating activities
-1
-2
-10
-16
-20
-29
Increase decrease in cash deposits released from restriction.
0
0
0
0
0
0
Purchases of fixed assets
0
0
0
0
-2
-2
Proceeds from disposals of fixed assets
0
0
0
0
0
0
Purchases of intangible assets
0
0
0
0
0
0
Net cash used in investing activities
0
0
0
0
-2
-2
Proceeds from issuance of common stock and warrants.
0
0
25
48
23
43
Proceeds from exercise of stock options
1
3
0
0
0
0
Proceeds from issuance of related party notes payable
0
0
0
0
0
0
Principal payments on capital lease obligations
0
0
0
0
0
0
Repayment of convertible notes and interest payable.
0
0
0
0
0
0
Deferred financing costs
0
0
0
0
0
0
Net cash provided by financing activities
1
2
25
48
23
43
Net increase in cash and cash equivalents
0
0
14
33
2
12
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Jun 10, 2014 n/a
calculated values,
restated on Jun 9, 2015 n/a
calculated values,
restated on Jun 9, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo